GlassScriptPhysician profile
John R Deitch
NPI 1770547069
$3,391.62
in general payments reported to CMS, 2019-2025
19 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2021: $283 · 2022: $124 · 2023: $659 · 2024: $1,664 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,564 · Travel and Lodging: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,564.37 |
| Travel and Lodging | $1,172.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,341.59 | 2023-2024 | |
| Smith+Nephew, INC. | $360.11 | 2021-2024 | Renasys Touch |
| Polynovo North America LLC | $266.83 | 2024-2025 | Novosorb Btm |
| Djo, LLC | $237.77 | 2023 | Donjoy, Aircast |
| Depuy Synthes Sales INC. | $231.51 | 2019-2021 | |
| Kuros Biosciences USA, INC | $158.34 | 2024 | Magnetos |
| Skeletal Dynamics INC | $114.74 | 2025 | Implate, Align, Ijs |
| Axogen | $114.29 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Biocomposites INC | $109.52 | 2025 | Stimulan |
| Sanara Medtech INC. | $105.70 | 2022 | |
| Avita Medical Americas, LLC | $66.12 | 2025 | Permeaderm, Cohealyx, Recell |
| Zimmer Biomet Holdings, INC. | $55.07 | 2021 | |
| Medtronic, INC. | $50.14 | 2025 | Aquamantys(Tm) |
| Novus Surgical Solutions LLC | $46.66 | 2019 | |
| Cerapedics INC. | $38.22 | 2023 | I-Factor Peptide Enhanced Bone Graft |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Consultants | $37.57 | 2024 | |
| Bard Peripheral Vascular, INC. | $21.65 | 2024 | Rotarexs 6 F X 135 Cm |
| Integra Lifesciences Corporation | $18.17 | 2022 | |
| Kerecis Limited | $17.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Deitch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.